NanoBioMed Lab
Research
Our core research domains, including nanomaterials, nanoparticles, drug delivery, biomaterials, tissue engineering, and nanomedicine. My work focuses on designing functional materials and integrating them into biomedical systems for applications in therapy, regeneration, and advanced healthcare technologies.
This research involves engineering nanocarrier-based drug delivery systems with surface-functionalized ligands for targeted therapy. We study their interaction with biological systems, including circulation, tumor targeting, cellular uptake, and controlled intracellular drug release to improve treatment specificity and efficiency.
This research is centered on the development of ROS-responsive polymeric nanoparticles for site-specific and stimuli-triggered drug delivery. I design systems capable of co-delivering drugs and genetic materials (siRNA), enabling controlled release in disease-specific microenvironments. The goal is to achieve enhanced therapeutic outcomes through targeted action, intracellular delivery, and combined chemo-gene therapy approaches, particularly for cancer and inflammatory diseases.
This work focuses on the integration of advanced nanomaterials (such as gold nanoparticles, carbon nanostructures, and mesoporous systems) with biomaterials and drug delivery platforms. I develop multifunctional systems combining chemotherapeutic drugs and gene therapy (siRNA) for targeted treatment. My research also explores disease-specific applications, including cancer therapy and inflammatory bowel disease, with an emphasis on improving therapeutic precision and biological response.
By integrating nanomaterials with natural and synthetic polymers, these scaffolds mimic the extracellular matrix and provide structural, electrical, and biochemical cues for cell growth. They support neurite guidance, controlled drug/growth factor release, and tissue regeneration. Such systems show strong potential for repairing neural damage and treating neurological disorders.
This work focuses on the development of 3D-printed polymeric microtube conduits for neural tissue engineering. We design microarchitectured scaffolds with aligned channels to guide axonal regeneration, support cell infiltration, and promote functional recovery in nerve injury applications.
Advanced smart nanoplatforms (MXenes, MOFs, Perovskites) enable controlled drug release, enhanced cellular uptake, and improved therapeutic efficiency while minimizing side effects. The image highlights the integration of nanotechnology with precision medicine for next-generation therapeutic applications.